These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 35943425)

  • 1. Retrobulbar Injection of Amphotericin B in Patients With COVID-19 Associated Orbital Mucormycosis: A Systematic Review.
    Sharifi A; Akbari Z; Shafie'ei M; Nasiri N; Sharifi M; Shafiei M; Zand A
    Ophthalmic Plast Reconstr Surg; 2022 Sep-Oct 01; 38(5):425-432. PubMed ID: 35943425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome of transcutaneous retrobulbar injection of liposomal amphotericin B in post-COVID-19 rhino-orbito-cerebral mucormycosis: Our experience.
    Ramamurthy LB; Bhandari R; Kanakpur S; Thejaswini P
    Indian J Ophthalmol; 2022 Mar; 70(3):1019-1024. PubMed ID: 35225564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rhino-orbital mucormycosis following COVID-19 in previously non-diabetic, immunocompetent patients.
    Nair AG; Adulkar NG; D'Cunha L; Rao PR; Bradoo RA; Bapaye MM; Kothari A; Dave TV; Shinde CA
    Orbit; 2021 Dec; 40(6):499-504. PubMed ID: 34338124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrobulbar injection of amphotericin B using intravenous cannula for post-COVID-19 rhino-orbital mucormycosis.
    Murthy R; Bagchi A; Gote Y; Desai S
    Indian J Ophthalmol; 2022 Jan; 70(1):302-305. PubMed ID: 34937263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is mucormycosis the end? A comprehensive management of orbit in COVID associated rhino-orbital-cerebral mucormycosis: preserving the salvageable.
    Keshri A; Mathialagan A; Aishwarya A; Ravisankar ; Bhuskute G; Kanaujia V; Singh AK; Singh RK; Dhiman RK; Agarwal R
    Eur Arch Otorhinolaryngol; 2023 Feb; 280(2):819-827. PubMed ID: 36053359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrobulbar Injection of Amphotericin B for Orbital Mucormycosis.
    Hirabayashi KE; Kalin-Hajdu E; Brodie FL; Kersten RC; Russell MS; Vagefi MR
    Ophthalmic Plast Reconstr Surg; 2017; 33(4):e94-e97. PubMed ID: 27768642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes and factors affecting them in patients with rhino-orbito-cerebral mucormycosis.
    Kashkouli MB; Abdolalizadeh P; Oghazian M; Hadi Y; Karimi N; Ghazizadeh M
    Br J Ophthalmol; 2019 Oct; 103(10):1460-1465. PubMed ID: 30514712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of transcutaneous retrobulbar Amphotericin B (TRAMB) as an adjuvant therapy for rhino-orbital-cerebral mucormycosis (ROCM) following COVID-19.
    Shakrawal J; Sharma V; Goyal A; Kumar D; Meena S; Tiwari S; Jain V; Elhence P; Soni K; Choudhury B; Bhatnagar K; Garg MK; Misra S
    Int Ophthalmol; 2023 Jun; 43(6):1919-1926. PubMed ID: 36427099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the globe salvaging treatment options in patients of COVID-19-associated mucormycosis with orbital involvement.
    Khare P; Chaurasia Y; Bhatnagar S
    Indian J Ophthalmol; 2022 Oct; 70(10):3638-3642. PubMed ID: 36190063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rhino-orbito-cerebral mucormycosis.
    Raymundo IT; Araújo BG; Costa Cde C; Tavares JP; Lima CG; Nascimento LA
    Braz J Otorhinolaryngol; 2009; 75(4):619. PubMed ID: 19784435
    [No Abstract]   [Full Text] [Related]  

  • 11. Transcutaneous Retrobulbar Amphotericin B Injection for Invasive Fungal Sinusitis with Orbital Involvement: A Systematic Review.
    Abdulbaki H; Callander JK; Fastenberg JH; Russell MS; Vagefi MR; Kersten RC; Loftus PA
    Am J Rhinol Allergy; 2024 Sep; 38(5):339-353. PubMed ID: 38772559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraconal amphotericin B for the treatment of rhino-orbital mucormycosis.
    Luna JD; Ponssa XS; Rodríguez SD; Luna NC; Juárez CP
    Ophthalmic Surg Lasers; 1996 Aug; 27(8):706-8. PubMed ID: 8858637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rhino-orbital mucormycosis during steroid therapy in COVID-19 patients: A case report.
    Veisi A; Bagheri A; Eshaghi M; Rikhtehgar MH; Rezaei Kanavi M; Farjad R
    Eur J Ophthalmol; 2022 Jul; 32(4):NP11-NP16. PubMed ID: 33843287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcutaneous retrobulbar injection of amphotericin B in rhino-orbital-cerebral mucormycosis: a review.
    Nair AG; Dave TV
    Orbit; 2022 Jun; 41(3):275-286. PubMed ID: 34720026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcutaneous retrobulbar amphotericin-B (TRAMB) injection in orbital mucormycosis.
    Singh P; Gupta A; Sanepalli SR; Raj A
    BMJ Case Rep; 2022 Mar; 15(3):. PubMed ID: 35361668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bilateral Rhino-Orbital-Cerebral Mucormycosis.
    Teixeira BM; Dias MQ; Castela G
    JAMA Ophthalmol; 2024 Jul; 142(7):e236486. PubMed ID: 39023643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcutaneous retrobulbar amphotericin B for rhino-orbital-cerebral mucormycosis: a multi-center retrospective comparative study.
    Dallalzadeh LO; Ediriwickrema LS; Fung SE; Men CJ; Kossler AL; Kupcha AC; Mawn LA; Burkat CN; van Landingham SW; Conger JR; Simmons B; Pham C; Akella SS; Setabutr P; Ho T; Couch SM; Kim JS; Demirci H; Korn BS; Kikkawa DO; Liu CY
    Orbit; 2024 Feb; 43(1):41-48. PubMed ID: 36880205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Presentations, Management and Outcomes of Rhino-Orbital-Cerebral Mucormycosis (ROCM) Following COVID-19: A Multi-Centric Study.
    Dave TV; Gopinathan Nair A; Hegde R; Vithalani N; Desai S; Adulkar N; Kamal S; Mittal R; Bradoo RA
    Ophthalmic Plast Reconstr Surg; 2021 Sep-Oct 01; 37(5):488-495. PubMed ID: 34314399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcomes of transcutaneous retrobulbar amphotericin B in COVID-19-associated mucormycosis.
    Rizvi SWA; Khan S; Shahbaz M; Gounder MS; Saif M; Khalid S
    Indian J Ophthalmol; 2023 Feb; 71(2):452-456. PubMed ID: 36727338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Refractory rhino-orbito-cerebral mucormycosis treated with intraconal amphotericin B.
    Guimarães JA; Moura FC
    Arq Bras Oftalmol; 2022; 85(1):77-81. PubMed ID: 34468552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.